If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Shareholder Information Request

14 Apr 2023 07:00

RNS Number : 2463W
Grupo Clarin S.A.
14 April 2023
 

 

 

GRUPO CLARIN S.A.

Grupo Clarín Responds to Shareholder Request for Additional Information

 

On 12 April 2023, Grupo Clarín S.A. (the "Company") informed the Argentine Securities Commission and the Buenos Aires Stock Exchange that it had exchanged additional notes with a shareholder in connection with the agenda of the Ordinary Annual Shareholders' Meeting to be held on 25 April 2023.

 

Attached as Exhibit A is a free translation of the Company's response.

 

Enquiries:

 

In Buenos Aires:

Samantha Olivieri

Grupo Clarín

Tel: +5411 4309 7104

Email: investors@grupoclarin.com

 

In London:

Alex Money

Jasford IR

Tel: +44 20 3289 5300

Email: alexm@jasford.com

 

In New York:

Camilla Ferreira / Marcella Ewerton

Fig Corporate Communications

Tel: +1 917 691 4047

Email: fig@fig.ooo

 

 

EXHIBIT A

 

FREE TRANSLATION

 

Buenos Aires, 12 April 2023

 

Mrs.

General Directorate for Strategic and Corporate Affairs

General Director Cecilia Gonzalez Bonorino

 

Directorate of Corporate Affairs

Mrs. Paola Rolotti

National Social Security Administration (ANSES) Fondo de Garantía de Sustentabilidad

 

 

By Hand

 

 

To whom it may concern,

 

I, Samantha Lee Olivieri, in my capacity as Person Responsible for Market Relations of Grupo Clarín S.A. (hereinafter, interchangeably, the "Company" or "Grupo Clarín") hereby address You in response to your request of clarification issued by e-mail dated 12 April 2023 regarding the information provided in relation to points 3), 7) and 12) of the agenda.

 

Below, as requested, is the information requested:

 

 

3) "Consideration of the performance of the members of the Board of Directors."

 

According to the minutes of the shareholders' meeting held for the appointment of authorities on 18 April 2022 (Filing 2883592), minutes of the meeting of the Board of Directors at which positions were allocated, held on the same date (Filing 2881617), the composition of the Board of Directors of the Company during fiscal year 2022 was the following:

 

Chairman: Jorge Carlos Rendo; Vice-Chairman: Héctor Mario Aranda; Directors: Felipe Noble Herrera, Alma Rocio Aranda, Horacio Ezequiel Magnetto, Francisco Pagliaro, Alberto César Menzani, Andrés Gabriel Riportella, Horacio Eduardo Quirós and Ignacio Rolando Driollet. Alternate Directors: Francisco Iván Acevedo, Martín Gonzalo Etchevers, Patricia Miriam Colugio, Alberto Pedro Marina, Eugenio Eduardo Sosa Mendoza, Marcelo Fernando Boncagni, Carlos Rebay, Luis Germán Fernández, Lucas Puente Solari and Alfredo Enrique Kahrs.

 

7) "Consideration of the compensation of the members of the Supervisory Committee for the economic year ended 31 December 2022."

 

The amount in the Column "Proposal 2022" refers to the sum of the advancements paid, as authorised by the Shareholders in the Shareholder Meeting dated 18 April 2022, to the members of the Supervisory Committee.

 

12) "Approval of the annual budget of the Audit Committee."

 

Following is the information requested.

 

 

.

Global Amount

Ps. 1,000,000

Ps. 1,200,000

Ps. 1,500,000

Ps. 2,800,000

Nominal Increase

Ps. 100,000

Ps. 200,000

Ps. 300,000

Ps. 1,300,000

Percentage Increase

11%

20%

25%

87%

 

 

The global amounts of Ps. 1,200,000 and Ps- 1,500,000 correspond to the amounts approved for the years 2021 and 2022 respectively.

 

 

Sincerely,

 

/s/ Samantha L. Olivieri

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRIIMITMTIBMFJ
Date   Source Headline
12th May 20151:00 pmRNSResults for the First Quarter 2015 (1Q15)
7th May 20156:12 pmRNSPayment of Cash Dividends
7th May 20157:54 amRNSNotice of Q1 2015 Results
30th Apr 20157:30 amRNSGCSA Holds Annual Ordinary Shareholders' Meeting
27th Apr 20157:17 amRNSGCLA responds to shareholder information request
24th Apr 20157:39 amRNSBoard Proposes External Auditors for 2015
16th Apr 20157:33 amRNSProposed Change in Allocation of Retained Earnings
30th Mar 20157:00 amRNSMinutes of the Meeting of the Board of Directors
18th Mar 20154:55 pmRNSGrupo Clarin to respond to appeal
18th Mar 20157:00 amRNSAnnual Financial Report
12th Mar 20153:45 pmRNSSecond Price Monitoring Extn
12th Mar 20153:40 pmRNSPrice Monitoring Extension
11th Mar 20155:58 pmRNSBoard Members' Fee Proposal
11th Mar 201512:00 pmRNSResults for Fourth Quarter and Full Year of 2014
5th Mar 20157:00 amRNSBoard Member Leave of Absence
2nd Mar 20157:00 amRNSNotice of Results
23rd Feb 20157:00 amRNSCourt grants injunction
15th Dec 20147:00 amRNSLeave of Absence Request
10th Dec 20147:00 amRNSCourt Grants Injunction
21st Nov 201412:49 pmRNSDividend Declaration
12th Nov 20143:45 pmRNSSecond Price Monitoring Extn
12th Nov 20143:40 pmRNSPrice Monitoring Extension
11th Nov 201412:03 pmRNSResults for Nine Months and Third Quarter of 2014
3rd Nov 20145:12 pmRNSCall and Presentation on 3rd Quarter Results
3rd Nov 20145:07 pmRNSCourt Grants Interim Injunction
10th Oct 20147:43 amRNSAFSCA Rejects Plan
10th Oct 20147:00 amRNSVice Chairman requests leave of absence
7th Oct 20147:21 amRNSBoard of Directors Receives Note from Shareholder
30th Sep 20143:45 pmRNSSecond Price Monitoring Extn
30th Sep 20143:40 pmRNSPrice Monitoring Extension
29th Sep 20144:13 pmRNSLeave of Absence request
25th Sep 20147:15 amRNSGCLA Holds Extraordinary Shareholders' Meeting
18th Sep 20147:00 amRNSGrupo Clarin shareholder summoned to Court
17th Sep 20147:40 amRNSGCLA Responds to Shareholder Information Request
21st Aug 20147:58 amRNSSteps Towards Media Law Compliance
18th Aug 20147:53 amRNSBoard of Directors Considers AFSCA Resolution
15th Aug 20147:00 amRNSAFSCA Rejects Request to Amend Proposal
11th Aug 20141:00 pmRNSResults for First Half and Second Quarter 2014
4th Aug 20143:46 pmRNSSecond Price Monitoring Extn
4th Aug 20143:40 pmRNSPrice Monitoring Extension
1st Aug 20145:30 pmRNSConference call to discuss Q2 2014 Results
15th Jul 20147:03 amRNSGCLA reconvenes Extraordinary Shareholders Meeting
14th Jul 20143:35 pmRNSOffers Relating to Unit 6 and other matters
2nd Jul 20147:14 amRNSGCLA holds Extraordinary Shareholders' Meeting
1st Jul 20147:22 amRNSGrupo Clarin Shareholders' Meeting Adjourned
30th Jun 20147:28 amRNSGCLA Considers Offers Related to Units 4, 5 and 6
25th Jun 20147:17 amRNSResponse to Shareholder Note
23rd Jun 20147:46 amRNSResponse to Shareholder Information Request
19th Jun 20147:39 amRNSPublication of Prospectus
9th Jun 20145:31 pmRNSBoard of Directors Receives Note from Shareholder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.